baber/WOPTO huggingface dataset:
Patent FI-892205-A0 (FI)
Inventor: GLEMET MICHEL
IPC: B29C48/21
Filed: 1989-05-08
Abstract: Process for the manufacture of thermoplastic resins reinforced with long fibres, consisting in impregnating rovings with a wetting thermoplastic polymer by means of a cross-head die and then taking up the said impregnated rovings in a second die where they are sheathed with thermoplastic polymer to be reinforced.
Patent FI-893102-A0 (FI)
Inventor: BECKER MANFRED
IPC: F16K31/04
Filed: 1989-06-26
Abstract: A valve control system includes a stepping motor coupled to an eccentric via a clutch. A valve member is urged into engagement with the eccentric by a spring. Rotation of the eccentric causes axial movement of the valve member which controls fluid flow through the valve. A detent releasably holds the eccentric in a neutral position.
Patent FI-896233-A0 (FI)
Inventor: GIRODEAU JEAN-MARC MARIE MAURI
IPC: C07C17/14
Filed: 1989-12-22
Abstract: The invention concerns a cycloalkane derivative of the formula I,   <CHEM>  wherein Ar<1> is optionally substituted phenyl or naphthyl; A<1> is (1-6C)alkylene, (3-6C)alkenylene, (3-6C)alkynylene or cyclo-(3-6C)alkylene; Ar<2> is optionally substituted phenylene, or a 6 membered heterocyclene moiety containing up to three nitrogen atoms; R<1> is hydrogen, (1-6C)alkyl, (3-6C)alkenyl, (3-6C)alkynyl, cyano-(1-4C)alkyl or (2-4C)alkanoyl, or optionally substituted benzoyl; and R<2> and R<3> together form a (3-6C)alkylene group which defines an optionally substituted ring having 4 to 7 ring atoms;  or a pharmaceutically-acceptable salt thereof. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.
Patent FI-911152-A0 (FI)
Inventor: KACIAN DANIEL LOUIS
IPC: G01N33/576
Filed: 1991-03-07
Abstract: Oligonucleotide probes for HIV nucleic acid are disclosed. Also disclosed are: methods of synthesizing multiple copies of a target nucleic acid sequence autocatalytically under conditions of substantially constant temperature, ionic strength, and pH are provided in which multiple RNA copies of the target sequence autocatalytically generate additional copies. These methods are useful for generating copies of a nucleic acid target sequence for purposes which include assays to quantitate specific nucleic acid sequences in clinical, environmental, forensic and similar samples, cloning and generating probes.
Patent FI-914952-A0 (FI)
Inventor: JUD WILFRIED
IPC: B65D75/58
Filed: 1991-10-21
Abstract: At a point (2) where the packaging material is doubled and forms the tubular package flaps where there is one of the two transverse sealing seams, a tubular package has a tab to aid in opening this transverse sealing seam. This tab may be formed by the end (7) of a fold (6) in the package material projecting from the package casing surface, the edge of a layer of the package material in the doubled region itself or an adhesive label (15) secured to this layer, whereby this doubled region (2) in the transverse sealing seam is advantageously wrapped with the label (15) over the end (18) of the package and the label (15) is secured to a region of the outer casing lying outside the doubled region (2) by a releasable adhesive or other seal within the area where it projects beyond the free edge of the doubled region (2) of the transverse sealing seam.
Patent FI-921264-A0 (FI)
Inventor: BASTIOLI CATIA
IPC: C08K5/10
Filed: 1992-03-24
Abstract: The material, which is usable for the production of biodegradable articles in film, sheet or fiber form, can be produced by extrusion from a molten mass including a synthetic thermoplastic polymer and a destructured starch to which a boron containing compound, such as boric acid, metaboric acid, borax and derivatives thereof has been added. Articles made of this material have improved transparency, Young's modulus and tear strength.
Patent FI-921764-A0 (FI)
Inventor: MARTIN FRANCIS J
IPC: A61K38/095
Filed: 1992-04-21
Abstract: A liposome composition for localizing an anti-tumor compound to a solid tumor via the bloodstream. The liposomes, which contain the agent in entrapped form, are composed of vesicle-forming lipids and between 1-20 mole percent of a vesicle-forming lipid derivatized with hydrophilic biocompatible polymer, and have sizes in a selected size range between 0.07 and 0.12 microns. After intravenous administration, the liposomes are taken up by the tumor within 24-48 hours, for site-specific release of entrapped compound into the tumor. In one composition for use in treating a solid tumor, the compound is an anthracycline antibiotic drug which is entrapped in the liposomes at a concentration of greater than about 50  mu g agent/ mu mole liposome lipid. The method results in regression of solid colon and breast carcinomas which are refractory to anthracycline antibiotic drugs administered in free form or entrapped in conventional liposomes.
Patent FI-923055-A0 (FI)
Inventor: MOISSET JACQUES
IPC: D21H27/30
Filed: 1992-07-01
Abstract: Paper usable as covering paper for plasterboard, characterised in that it consists of a sheet of covering paper for plasterboard coated with a pigment layer, in that the ply of the paper sheet to which the said pigment layer is applied is based on at least one inorganic filler of light, and preferably white, colour and on bleached, predominantly chemical, new or recovered cellulose fibres, in that the said pigment layer is based on at least one inorganic filler of light, and preferably white, colour, of chemical nature which is identical with or different from that of the inorganic filler forming the said ply, at least one binder and, if necessary, various adjuvants making it possible to prepare a pigment slip of appropriate rheology, and in that the weight of the deposited pigment layer is at least 6 g/m<2>.
Patent FI-931681-A0 (FI)
Inventor: STEG HANS-HENNING
IPC: A61B5/145
Filed: 1993-04-14
Abstract: The piercing component at its free end pointing away from the handgrip has a lancet with a pointed end for targeted introduction into the skin. The handgrip (13) is formed at least partially as a spring-elastic body in the form of a membrane (20). The membrane is formed as a plate-shaped body which in cross-section is concavely arched. The piercing component on its shaft part has projections (24,25) which work in conjunction with corresp. projections in the inner space of the bush component. <IMAGE>
Patent FI-933251-A0 (FI)
Inventor: RICHARDSON C DOUGLAS
IPC: H04M3/32
Filed: 1993-07-16
Abstract: A telecommunications system having 1:n group facility protection is disclosed. Two cross-connects (2A, 2B) are provided, each organized in a distributed fashion, and which have a group of member ports (MA, MB) bidirectionally coupled to one another in corresponding fashion via a plurality of paths (4), such as of the DS-3 data frame type. Each of the cross-connects (2A, 2B) also include a bidirectional protection port (PA, PB), coupled to the protection port (PB, PA) of the other cross-connect (2B, 2A) by way of a protection path (P), also preferably of the DS-3 type; the protection port (PA, PB) for each cross-connect (2A, 2B) is assigned to the member port group (MA, MB), and is implemented to be managed by the same distributed interface processing unit (16) as the protected member port group (MA, MB). The cross-connects (2A, 2B) monitor (30) their member input ports (MA, MB) for received facility errors, such as signal failures (SF) or excessive failure rates, and request (34) a third-stage bridge from its mate cross-connect (2B) in the event of such error. Upon receipt of a good signal at the protection input port (PAI), the requesting cross-connect (2A) effects (38) a first stage switch (1SSW), so that the previously failing facility is received over the protection path (P). Communication of request and acknowledge signals over the protection path (P) is preferably by way of the C-bit and X-bit channels, for DS-3 paths. The switch preferably reverts (72) to the normal condition responsive to the facility becoming valid for a timeout period at the original member port (MA1I). <IMAGE>   <IMAGE>   <IMAGE>
Patent FI-933597-A0 (FI)
Inventor: MATTLAR HARRI
IPC: H01H19/635
Filed: 1993-08-13
Abstract: PCT No. PCT/FI94/00328 Sec. 371 Date Feb. 13, 1996 Sec. 102(e) Date Feb. 13, 1996 PCT Filed Jul. 20, 1994 PCT Pub. No. WO95/05673 PCT Pub. Date Feb. 23, 1995A manually operated switch device for the control of electrical equipment, wherein the electrical elements of the switch are assembled in a housing and the mechanical elements are mounted on a body piece attached to the housing. At least one linearly transferrable slide member communicates with the body piece, the slide member having contact or guide surfaces adapted to cooperate with the stationary contacts. To the slide member is connected via at least one spring-type element, a power-spring-arming plate which is movable in parallel relationship with the slide member, in such a manner that during the movement of the power-spring-arming plate, the slide member is correspondingly moved under the force exerted by the power springs. By virtue of this arrangement, the switching phase always occurs in a consistent manner, irrespective of the speed used for rotating the switch operating lever.
Patent FI-934821-A0 (FI)
Inventor: WINTERSON WARREN D
IPC: A23L19/00
Filed: 1993-10-29
Abstract: A process for reordering tobacco, which results in no significant decrease in equilibrium tobacco CV or significant tobacco degradation, is provided. Tobacco to be reordered is contacted with an air stream having a relative humidity near the equilibrium conditions of the tobacco. As the ov content of the tobacco increases, the relative humidity of the air stream contacting the tobacco is increased to affect reordering of the tobacco. Also provided is a process for drying tobacco, which results in no significant change in equilibrium tobacco CV or significant tobacco degradation. Tobacco to be dried is contacted with an air stream having a relative humidity near or below the equilibrium conditions of the tobacco. As the OV content of the tobacco decreases, the relative humidity of the air stream contacting the tobacco is decreased to affect drying of the tobacco. It has been found that tobacco can be reordered or dried successfully in a continuous manner using a self-stacking spiral conveyor. <IMAGE>
Patent FI-945549-A0 (FI)
Inventor: FRENZ JOHN
IPC: C07K1/22
Filed: 1994-11-25
Abstract: The present invention provides the identification and characterization of two components of a recombinant preparation of DNase. These components are the purified deamidated and non-deamidated human DNases. Taught herein are the separation of these components and the use of the non-deamidated species as a pharmaceutical per se, and in particular in compositions wherein the species is disclosed within a plastic vial, for use in administering to patients suffering from pulmonary distress.
Patent FI-951991-A0 (FI)
Inventor: BARRE GUY
IPC: B01J35/10
Filed: 1995-04-26
Abstract: A process for the preparation of a lubricating base oil including contacting a hydrocarbon feed with a catalyst in the presence of hydrogen, which catalyst includes a hydrogenation component supported on an amorphous silica-alumina carrier having a macroporosity in the range of from 5% vol to 50% vol. The hydrocarbon feed is most preferably a slack wax or a synthetic wax. The preferred catalyst for use in the process includes a combination of one or more of the metals cobalt, iron, and nickel, and one or more of the metals chromium, molybdenum, and tungsten on an amorphous silica-alumina carrier having a macroporosity in the range of from 5% vol to 50% vol.
Patent FI-954257-A0 (FI)
Inventor: AICHER THOMAS D
IPC: C07D498/04
Filed: 1995-09-11
Abstract: The invention concerns oxazole and thiazole compounds of formula <CHEM> where the substituents have various significances, in free form or salt form as appropriate. They can be prepared e.g. by coupling or hydrolysis. The compounds can be used as pharmaceuticals, especially as hypoglycemic agents in the treatment of diabetes.
Patent FI-954504-A0 (FI)
Inventor: MURRAY CAMERON R
IPC: C12H1/18
Filed: 1995-09-22
Abstract: A process for preparing a fermented malt beverage wherein brewing materials are mashed with water and the resulting mash is heated and wort separated therefrom. The wort is boiled, cooled and fermented and the beer is subjected to a finishing stage, which includes aging, to produce the final beverage. The improvement comprises subjecting the beer to a cold stage comprising rapidly cooling the beer to a temperature of about its freezing point in such a manner that ice crystals are formed therein in only minimal amounts. The resulting cooled beer is then mixed for a short period of time with a beer slurry containing ice crystals, without any appreciable collateral increase in the amount of ice crystals in the resulting mixture. Finally, the so-treated beer is extracted from the mixture.
Patent FI-955222-A0 (FI)
Inventor: HABLUETZEN RICHARD
IPC: H02G3/12
Filed: 1995-11-01
Abstract: A base element (1) is fixed on the brickwork and a support (3) forming a rectilinear guide track projects away from same at right angles. This support is prismatic and the base element is mounted across the longitudinal axis to protrude radially on all sides over the support. A guide (13) which telescopes with the support is provided on the anchorage element (6) which is longitudinally displaceable on the support. The guide (13) is mounted on the reverse side of the anchorage element opposite the assembly face. The anchorage element has an aperture coaxial with the longitudinal axis of the support.
Patent FI-961789-A0 (FI)
Inventor: KAHILAINEN JUKKA
IPC: H01L27/14
Filed: 1996-04-26
Abstract: Detecting ionising radiation comprises use of a dosimeter which incorporates a MOSFET transistor (10) provided with a floating gate (13).The ionizing radiation is allowed to affect the surface of the floating gate (13) of MOSFET transistor (10) through an open air or gas space or a closed air or gas space (24). For this purpose, an uncovered area (17) is formed on the surface of floating gate (13), or there is an area covered by a conductor, semiconductor or insulator. Also claimed is an ionising radiation detector/dosimeter comprising a MOSFET transistor (10) provided with a floating gate (13). A part of the surface of gate (13) is uncovered, or covered by a conductor, semiconductor or thin insulator. The floating gate surface is located in an open air or gas space or closed air or gas space.
Patent FI-972079-A0 (FI)
Inventor: FREDIN PER
IPC: G02B23/02
Filed: 1997-05-15
Abstract: An electro-optic sight, for detecting incoming optical radiation is described. It comprises frontal optics (1) through which radiation along the optical axis, the sight line (3) of the sight passes on its way to platform optics (2) rigidly connected to the frontal optics, which platform optics guide the incoming radiation further to a detector unit (5) in which the incoming radiation is converted to a picture. The electro-optical sight is primarily characterized in that the platform optics (2) are so arranged that, through turning about a first axis, yaw axis (7), and a second axis, pitch axis (8), they direct the optical axis for forwarding to the detector unit (5), the radiation being guided through a system of a first, second, third and fourth prism (13-16) through reflexion, said prisms being mounted in a common structure, which is turnable about the first axis, which coincides with the optical axis, that is said sight line (3), the first prism (13) being turnable relative to the second prism (14) about the second axis, which constitutes the direction of the optical axis reflected from the first prism.
Patent FI-972630-A0 (FI)
Inventor: HEATON DAVID WILLIAM
IPC: A61P43/00
Filed: 1997-06-18
Abstract: PCT No. PCT/GB95/02997 Sec. 371 Date Jun. 23, 1997 Sec. 102(e) Date Jun. 23, 1997 PCT Filed Dec. 21, 1995 PCT Pub. No. WO96/20169 PCT Pub. Date Jul. 4, 1996A new salt of a prodrug useful in antibody directed enzyme prodrug therapy (ADEPT) is disclosed. A hydrogen iodide salt of the prodrug N-(4-[N,N-bis(2-iodoethyl)amino]phenoxycarbonyl)-L-glutamic acid is prepared which can be obtained in crystalline form. Preparation of the crystalline form of the prodrug enables preparation of the prodrug in highly pure form.
Patent FI-973118-A0 (FI)
Inventor: BROWNING JEFFREY L
IPC: A61K39/395
Filed: 1997-07-25
Abstract: A method (A) for treating or reducing the advancement, severity or effects of neoplasia, comprises: administering: (i) a lymphotoxin (LT)-alpha /beta heteromeric complex (LHC) and a carrier, or (ii) >= 1 LT-beta receptor (LT-beta -R) activating agent and a carrier. Also claimed are: (1) a method (B) for selecting a LT-beta -R activating agent which acts in the presence of a LHC, comprising: (a) culturing tumour cells in the presence of LHCs, a first LT-beta -R activating agent and a second putative LT-beta -R activating agent; and (b) determining whether the second putative LT-beta -R activating agent increases the anti-tumour activity of the LHC in the presence of the first LT-beta -R activating agent; (2) a pharmaceutical compsn. comprising an LHC and a carrier; (3) a pharmaceutical compsn. comprising >= 1 LT-beta -R activating agent without exogenous LHC and a carrier, and (4) a pharmaceutical compsn. comprising cross-linked anti-LT-beta -R antibodies as a LT-beta -R activating agent and a carrier.
Patent FI-981184-A0 (FI)
Inventor: TURUNEN MATTI
IPC: H04W88/18
Filed: 1998-05-27
Abstract: The invention relates to a method for transmitting multimedia messages to a wireless terminal (MS 1 ) in a data transmission system which comprises at least one mobile communication network (HPLMN) and at least one multimedia message server (MMSV). In the method, each wireless terminal (MS 1 ) connected to the mobile communication network (HPLMN), is allocated an address specifying said wireless terminal (MS 1 ), and at least one data transmission connection is activated for said wireless terminal (MS 1 ). Information on the activation of the data transmission connection for said terminal (MS 1 ) is transmitted to the multimedia message server (MMSV).
Patent AP-9801396-A0 (AP)
Title: An apparatus called pit latrine slab for use as for pit latrine or trenches and method of manufacture of this pit latrine slab.
Inventor: SHAH NIKHIL
Filed: 1998-10-26
Abstract: A pit latrine slab of any design with a substantially rectangular shape and with a relatively flat shape and of any dimensions, designed to incorporate as integral parts of the slab, or alternatively to make provision for, moulded-in throughholes for affixing to the slab a vent pipe of any dimensions and/or moulded-in throughholes of any dimension for affixing tubes to form a frame and/or moulded-in throughholes for affixing the slab to the ground, and also designed to incorporate a central key hole for drainage and two slightly raised food rests adjacent to the central key hole and a designed to incorporate a slightly downward slope from the four corners towards the central key hole for drainage and to incorporate also the desired number of kiss-off points of the desired dimensions to provide strength to the slab, the said slab being made of polyethylene and/or foamed polyethylene or other suitable polymer and/or foamed polymer by roational moulding process or other suitable plastic moulding process.
Patent IL-62197-A0 (IL)
Title: Hetero-imino-prostacycline
IPC: C07D307/93
Filed: 1981-02-23
Abstract: What are disclosed are prostacylin PGI2 analogs of the formula <IMAGE>   having a more specific or longer lasting pharmacological action than PGI2, methods of making these analogs; and methods and pharmaceutical preparations for inhibiting blood platelet aggregation, for treating hypertension, for the treatment or prophylaxis of gastrointestinal ulcers, and for the treatment of asthma.
Patent IL-69891-A0 (IL)
Title: Process for the production of composite alloys based on aluminium and boron
IPC: C22C1/00
Filed: 1983-10-03
Abstract: PCT No. PCT/FR83/00199 Sec. 371 Date Jun. 4, 1984 Sec. 102(e) Date Jun. 4, 1984 PCT Filed Oct. 4, 1983 PCT Pub. No. WO84/01390 PCT Pub. Date Apr. 12, 1984.The present invention relates to a process for the production of composite alloys based on aluminum, which may or may not be alloyed, and containing up to 30% by weight of boron. The process is characterized in that the boron is introduced into the liquid aluminum in the form of aluminum boride having the formula AlB2 or AlB12. It finds application in the production of composite alloys which are resistant to abrasion or which are intended to serve as neutron barriers in air or an aqueous medium.
Patent IL-73514-A0 (IL)
Title: Self-adhesive sheet-like structures and their preparation
IPC: C08G18/08
Filed: 1984-11-14
Abstract: The present disclosure is concerned with self-adhesive sheet-like structures made by adhering an adhesive polyurethane gel material to a supporting substrate and the utilization of such structures in the medical field to adhere materials such as plasters, wound dressings and appliances to the human body, and in other fields to connect articles, such as the parts of a fractured or cracked object, to one another by means of an adhesive bond. The gel is formed by immobilizing a high molecular weight polymeric polyol in the matrix of a covalently crosslinked polyurethane which is prepared by reacting polyisocyanates having an isocyanate functionality of at least 2 with higher molecular weight polyhydroxyl compounds having a hydroxyl functionality of at least 3. These reactants are selected in accordance with the following formula which relates the isocyanate number, K, (isocyanate to hydroxyl equivalents ratio times 100) to the average functionalities of the polyisocyanates (FI) and of the polyhydroxyl compounds (FP) as follows:   <IMAGE>   wherein X is less than or equal to 120. These reactants are also selected to give a weight ratio of matrix to immobilized polymeric polyol of between about 15:85 and 62:38.
Patent FI-20065827-A0 (FI)
Inventor: IKAEVALKO HEIKKI
IPC: B65D/
Filed: 2006-12-20
Abstract: The invention relates to a package for a pet or domestic animal nutrient, the package comprising a material layer surrounding and protecting the nutrient. The material layer surrounding the nutrient is made of a material, which is edi- ble to domestic animals or pets.
Patent IL-101092-A0 (IL)
Title: Herbal extract composition
IPC: A23L29/00
Filed: 1992-02-27
Abstract: Herbal Extract Composition containing a Melissa species extract, an Avena species extract and a Tilia species extract; a Modified Herbal Extract Composition containing additional herbal extracts; a Beverage Concentrate containing the Modified Herbal Extract Composition; and a beverage made from the Beverage Concentrate dissolved/dispersed in water.
Patent IL-105669-A0 (IL)
Title: Dithiolanylglycine-containing hiv protease inhibitors of the hydroxyethylene isostere type,their preparation and pharmaceutical compositions containing them
IPC: C07D215/48
Filed: 1993-05-11
Abstract: The invention relates to dithiolanylglycine-containing HIV protease inhibitors of the hydroxyethylene isostere type of the general formula (I) <IMAGE> to a process for their preparation and to their use as retroviral agents.
Patent IL-114499-A0 (IL)
Title: Pyrido (3,2,1-i,j)(3,1) benzoxazine derivatives pharmaceutical compositions containing them and their use
IPC: A61K31/535
Filed: 1995-07-07
Abstract: PCT No. PCT/EP95/02510 Sec. 371 Date Jan. 3, 1997 Sec. 102(e) Date Jan. 3, 1997 PCT Filed Jun. 28, 1995 PCT Pub. No. WO96/01829 PCT Pub. Date Jan. 25, 1996Disclosed are pyrido[3,2,1-i,j][3,1]benzoxazine compounds of the formula (I):    <IMAGE>  (I)  wherein z represents a radical having the formula:, -O- or a direct bond; and the other variables in formula (I) and Z are as described herein. The compounds have antibacterial properties and also disclosed are antibacterial compositions containing them and methods of using them to prevent or combat bacterial infections. Methods for preparing the compounds are also disclosed.